Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 25(12): 2378-2385, 2014 Dec.
Article
in En
| MEDLINE
| ID: mdl-25294886
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Genes, ras
/
Colonic Neoplasms
/
Mutation
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2014
Type:
Article